Lisata Therapeutics reported raising $352 Million in an initial SEC Form D filing, from an offering of $352 Million
Amount Raised
$352 Million
Round Type
Series C
Basking RidgeBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Lisata Therapeutics has announced the acquisition of Marea Therapeutics along with a concurrent financing of $225 million. This private placement financing aims to support operations and advance clinical milestones for key therapies. Leading life sciences investors participated in this oversubscribed financing. The proceeds will primarily be used to advance MAR001/005 and MAR002 through key clinical trials.
Quick answer
Lisata Therapeutics raised $352 Million in a Series C round, dated September 17, 2026. Investors: venBio, Rock Springs Capital, Affinity Asset Advisors, Llc, Nantahala Capital, Columbia Threadneedle Investments, Surveyor Capital, Omega Funds and Sofinnova Investments. Lisata Therapeutics is based in Basking Ridge, New Jersey, United States.
- How much did Lisata Therapeutics raise?
- Lisata Therapeutics raised $352 Million in a Series C round on September 17, 2026.
- Who invested in Lisata Therapeutics?
- venBio, Rock Springs Capital, Affinity Asset Advisors, Llc, Nantahala Capital, Columbia Threadneedle Investments, Surveyor Capital, Omega Funds and Sofinnova Investments are named as investors in this round.
- What does Lisata Therapeutics do?
- Lisata Therapeutics Inc (NASDAQ:LSTA) is a pharmaceutical company that is partnering with the University of Cincinnati to investigate endometriosis therapy.
- Where is Lisata Therapeutics based and how big is it?
- Lisata Therapeutics is based in Basking Ridge, New Jersey, United States. Fundz records about 42 employees.
- Who are the decision-makers at Lisata Therapeutics?
- Fundz holds 2 contacts at Lisata Therapeutics, including the Senior Vice President, Business Development & Licensing, Operations and General Counsel. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Lisata Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Quanta Therapeutics raised an undisclosed amount (Series D) on October 24, 2026.
- Trior raised $25M (Series C) on October 23, 2026.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- Disc raised $422M (Post-IPO Equity) on October 20, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
- Acta Pharmaceuticals raised $24M (Seed) on October 15, 2026.
Who to call at Lisata Therapeutics, and when
A new round usually means Lisata Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lisata Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lisata Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lisata Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lisata Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lisata Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.